معرفی
Dr. Min Tan is a Senior Research Fellow at Monash University's Department of Diabetes, part of the Centre for Inflammatory Disease at Monash Health. She holds a BBiomedSci (Therapeutics) and BSci with Honours from the University of Melbourne, where she also completed her PhD in 2011 on therapies for pathological fibrosis in heart and kidney failure. After her postdoctoral work at the Baker Heart & Diabetes Institute, she joined Monash University in 2016, leading research programs in diabetic complications and immunotherapy. She leads the Regulatory T Cells Therapies Research Group, focusing on immunotherapy for diabetes and its complications.
Education:
- BBiomedSci (Therapeutics), University of Melbourne
- BSci with Honours, University of Melbourne
- PhD in Diabetes and Fibrosis, University of Melbourne (2011)
Research Interests: Dr. Tan's work centers on the role of complement pathways in diabetic complications, particularly in kidney disease. Her research explores inflammation, oxidative stress, and novel therapies targeting fibrosis and immune mechanisms. Recent projects include investigating complement receptors in diabetic kidney disease and regulatory T cell therapies.
Grants & Projects:
- NHMRC Ideas Grant (2022): Investigating complement receptors in diabetic kidney disease
- Diabetes Australia-funded project (2023-2024): Boosting regulatory T cells for kidney disease treatment
Awards:
- Australia and New Zealand Society of Nephrology Basic Science Award (2022)
- Monash FMNHS Exceptional Achievement (2022)
Advising & Collaboration: Dr. Tan has supervised multiple honours and master's students on topics like mitochondrial signatures in kidney disease and complement cascade analysis. She collaborates widely on projects addressing diabetic complications and therapeutic targets.
